Recently, we identified a novel and important cytoskeletal component of breast cancer cell invadopodia, namely, cysteine- and glycine-rich protein 2 (CRP2) (Hoffmann et al., 2016; Hoffmann et al., 2018). The gene discussed is CRIP2; the disease is breast carcinoma.